They showed higher mutation rate of MSH3, MSH6, APC and PI3KCA in Iranian patients, hypothesizing a major role of these genes in CRC and suggesting the adoption of specific informed genetic diagnosis protocol and tailored therapy in this population. Here, MSH3 is linked to colorectal carcinoma.